Genenta Science S.p.A. GNTA

Latest FY: 2025 Healthcare Biotechnology
Market Price $1.00
Market Cap $23.43M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025)
N/A
Full year reported
Net Income ↑26.7% YoY
-$6.53M
Net Margin: N/A
Free Cash Flow ↓-10.1% YoY
-$6.88M
FCF Yield: -29.34%
EPS (Diluted) ↑32.7% YoY
$-0.33
Basic: $-0.33
Return on Equity Efficiency
-29.9%
ROA: -20.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (GNTA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $-4.6M $-2.5M
FY 2020 $-5.6M -21.6% $-6.0M $-6.1M
FY 2021 $-5.5M +1.1% $-0.37 0.00% $-7.0M $-7.0M -14.9%
FY 2022 $-8.5M -53.3% $-0.47 -27.0% 0.00% $-7.4M $-7.4M -6.9%
FY 2023 $-11.6M -37.4% $-0.64 -36.2% 0.00% $-11.2M $-11.2M -50.7%
FY 2024 $-8.9M +23.5% $-0.49 +23.4% 0.00% $-6.2M $-6.2M +44.3%
FY 2025 $-6.5M +26.7% $-0.33 +32.7% 0.00% $-6.9M $-6.9M -10.1%
$

Valuation

Market Price $1.00
Market Cap $23.43M
Enterprise Value $25.51M
P/E Ratio N/A
P/B Ratio 1.07
FCF Yield -29.34%
Dividend Yield 0.00%
Shares Outstanding 23,432,183
%

Profitability & Margins

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) -29.90%
Return on Assets (ROA) -20.48%
Asset Turnover 0.00x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 14.16
Cash Ratio 2.61
Debt / Equity 0.348
Debt / Assets 0.238
Cash & Equivalents $5.53M
Total Debt $7.60M
Book Value / Share $0.93
💧

Cash Flow Efficiency

Operating Cash Flow -$6.87M
Capital Expenditures (CapEx) $7.62K
Free Cash Flow -$6.88M
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.33
EPS (Basic) $-0.33
Dividends / Share N/A
Book Value / Share $0.93
EPS YoY Growth 32.65%
🏛️

Balance Sheet (FY 2025)

Total Assets $31.89M
Total Liabilities $10.05M
Stockholders' Equity $21.84M
Current Assets $29.98M
Current Liabilities $2.12M